Visual Function Evaluation through Follow-up after COVID-19 Vaccination-Reference-Cited by-同舟云学术

Visual Function Evaluation through Follow-up after COVID-19 Vaccination

Published:2022-09-30 Issue:3 Volume:27 Page:209-214
ISSN:1226-5012
Container-title:Journal of Korean Ophthalmic Optics Society
language:en
Short-container-title:jkoos

Author:

Wee Sung-Hyun^ORCID,Cho Hyun Gug^ORCID,Yu Dong-Sik^ORCID,Kim Sang-Yeob^ORCID,Moon Byeong-Yeon^ORCID

Publisher

The Korean Opthalmic Optics Society

Subject

General Medicine

Reference10 articles.

1. EMA(European Medicines Agency). Committee for Medicinal Products for Human Use (CHMP): Assessment Report –Comirnaty (Pfizer/BioNTech), 2021. https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf(7 May 2021).

2. EMA(European Medicines Agency). Committee for Medicinal Products for Human Use (CHMP): Assessment Report - COVID-19 Vaccine AstraZeneca, 2021. https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar?public-assessment-report_en.pdf(7 May 2021).

3. EMA(European Medicines Agency). Committee for Medicinal Products for Human Use (CHMP): Assessment Report - COVID-19 Vaccine Moderna, 2021. https://www.ema.europa.eu/en/documents/assessment-report/covid-19-vaccine-moderna-epar-public-assessment-report_en.pdf(7 May 2021).

4. Medicines and Healthcare Products Regulatory Agency. Coronavirus Vaccine - Weekly Summary of Yellow Card Reporting, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043829/Coronavirus_vaccine_-_summary_of_Yellow_Card_reporting_15.12.2021_VRMM_FINAL.pdf(29 December 2021).

5. Korea Disease Control and Prevention Agency. Weekly Adverse Events after COVID-19 Vaccination, 2022. https://ncv.kdca.go.kr/upload_comm/syview/doc.html?fn=165484771828700.pdf&rs=/upload_comm/docu/0032/(11 Jun 2022).